Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Oral Apremilast effectively treats alopecia areata in most patients.

SLE and DM can coexist but are rare and need careful evaluation.

Patients on long-term hemodialysis often have skin problems related to their treatment.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Stag parts were historically used in medicine for various health issues.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Early identification of lupus through skin signs and blood tests is crucial in India.

The new gel for psoriasis is effective, stable, and easy to apply.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.